The findings elucidate the mechanism behind the upregulation of MAD2L1 in murine tumors associated with a high‐sugar diet as reported in prior study and suggest a novel therapeutic strategy of targeting RCC2 lactylation to restrict the rapid proliferation of breast cancer cell in a high‐lactate microenvironment. This evidence concerns the gene RCC2 and breast carcinoma.